These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5317063)
1. The conformation of histamine. An application of quantum chemistry to pharmacology. Margolis S; Kang S; Green JP Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):279-83. PubMed ID: 5317063 [No Abstract] [Full Text] [Related]
2. Serotonin. II. structural variation and action. Offermeier J; Ariƫns EJ Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):216-45. PubMed ID: 6008411 [No Abstract] [Full Text] [Related]
3. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats. Sloviter RS; Drust EG; Damiano BP; Connor JD J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720 [No Abstract] [Full Text] [Related]
5. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens. Martin WR; Eades CG Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035 [No Abstract] [Full Text] [Related]
6. An electrophysiological analysis of hallucinogens. Cowen MA; Nishi H; Hammack D Biol Psychiatry; 1973 Dec; 5(3):239-56. PubMed ID: 4708679 [No Abstract] [Full Text] [Related]
7. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data. Kumbar M; Sankar DV Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018 [No Abstract] [Full Text] [Related]
8. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens. Martin WR; Sloan JW Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624 [No Abstract] [Full Text] [Related]
9. The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain. Smythies JR; Benington F; Morin RD Int Rev Neurobiol; 1970; 12():207-33. PubMed ID: 4918144 [No Abstract] [Full Text] [Related]
10. Structure-activity-relationships of certain hallucinogenic substances based on brain levels. Vogel WH; Evans BD Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244 [No Abstract] [Full Text] [Related]
11. Transmitter role of serotonin in identified synapses in Aplysia nervous system. Paupardin-Tritsch D; Gerschenfeld HM Brain Res; 1973 Aug; 58(2):529-34. PubMed ID: 4356938 [No Abstract] [Full Text] [Related]
12. Failure of N,N-dimethyltryptamine to evoke tolerance in cats. Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415 [No Abstract] [Full Text] [Related]
13. Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety. Kline TB; Benington F; Morin RD; Beaton JM J Med Chem; 1982 Aug; 25(8):908-13. PubMed ID: 7120280 [TBL] [Abstract][Full Text] [Related]
15. [The drug experience as a biological problem]. Stille G Schweiz Med Wochenschr; 1971 Sep; 101(35):1257-69. PubMed ID: 4947024 [No Abstract] [Full Text] [Related]
16. Action of biogenic amines on crustacean chromatophores. II. Analysis of the responses of erythrophores in the fiddler crab, Uca pugilator, to indolealkylamines and an eyestalk hormone. Rao KR; Fingerman M Comp Gen Pharmacol; 1970 Mar; 1(1):117-26. PubMed ID: 5317389 [No Abstract] [Full Text] [Related]